Anthem Biosciences schedules Q1 FY27 earnings call for July 22, 2026

Board & Shareholder Meetings View source PDF

ANTHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+3.7%1-day move

₹749.85

prior close

₹754.80

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

+0.0-0.1-0.6-0.6+3.7+5.3+5.9+4.0+4.3+5.2————

Up moveDown movePending

AI summary

Anthem Biosciences has scheduled an earnings conference call on Wednesday, July 22, 2026 at 11:30 AM IST to discuss its unaudited standalone and consolidated financial results for Q1 FY27, quarter ended June 30, 2026. MD and CEO Ajay Bhardwaj and CFO Gawir Baig will lead the discussion. Investors can join via Diamond Pass pre-registration or dial-in numbers.

Likely market impact

Investors can listen to management commentary on Q1 performance, which may offer insights into revenue, margins and outlook for the stock.